The Treatment of Benign Prostate Hyperplasia in High Risk Patients by Transurethral Electrovaporization

Objective:In order to evaluate the validity and safety of transurethral electrovaporization of benign prostatic hyperpasia in high risk patients. Methods:70 cases of BPH were retreated by transurethral electrovaporization and had been followed up at 6 and 14 months.Clinical data were collected and analysis. Results: The mean operative time was 45 min (range 30～110 min), Qmax increased form (6.8±2.8) mL/s to (20.2±3.2) mL/s, IPSS decreased from (25.4±3.6) to (7.2±1.3), QOL decreased from (5.0±0.5) to (2.4±0.5) and post void residual from (90.2±15.5)mL to (15.6±13.8)mL at 3 months postoperatively(P0.01). Conclusions: Transurethral electrovaporization of prostate is safe and effective with less complications and good result for high risk patients with BPH, it is recommended to perform in county hospital.